Olwen Hahn to Cyclooxygenase 2
This is a "connection" page, showing publications Olwen Hahn has written about Cyclooxygenase 2.
Connection Strength
0.148
-
Phase III Randomized, Placebo-Controlled, Double-Blind Trial of Celecoxib in Addition to Standard Chemotherapy for Advanced Non-Small-Cell Lung Cancer With Cyclooxygenase-2 Overexpression: CALGB 30801 (Alliance). J Clin Oncol. 2017 Jul 01; 35(19):2184-2192.
Score: 0.148